Dr Daniel Goldberg, a leading New Jersey ophthalmologist is coordinating a new study to measure the effectiveness of using 5% Betadine irrigation for treatment of acute EKC- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.
The purpose of the new study is to confirm the effectiveness of this protocol and to expand the awareness amongst eye care professionals of this inexpensive treatment for EKC.
The treatment of EKC using betadine has been widely debated for years, but new research is shedding positive light on the treatment. The Ocular Surgery News website, www.osnsupersite.com, recently interviewed Dr Goldberg about his new study and about using betadine as a treatmentn for EKC.
To read the full interview and article on the Ocular Surgery News website, visit http://www.osnsupersite.com/view.aspx?rid=41471
Participation in the study is open to ophthalmologists, US and international, who agree to follow the protocol and report clinical results thru the Betadine for EKC website (http://www.betadineforekc.com/Default.aspx ). The initial phase will be collecting data thru October 1, 2009, and it is anticipated that subsequently there will be modifications to the protocol and study design.
For more information about the new study, please visit http://www.betadineforekc.com/the-study.aspx
Information on registration is available at http://www.betadineforekc.com/submission-process.aspx
Tags: betadine for ekc, dr daniel goldberg, treatment for ekc